Arabic Arabic English English French French German German
dark

Glaxo, SK bioscience start final trial of COVID jab

British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a COVID-19 jab after positive early results, they announced Tuesday. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Israel registers record daily coronavirus cases

Next Post

Key immune cells maintain healthy gut bacteria to protect against colorectal cancer

Related Posts
Total
0
Share